中文名 | 非布索坦 |
英文名 | Febuxostat |
别名 | 非布索坦 非布司他 非布索坦杂质V 非布司他对照品 非布索坦(标准品) 2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸 |
英文别名 | FBX Uloric Febuxostat FEBUXOSTAT API Febuxostat Tablets Febuxostat (Uloric) Febuxostat (TEI-6720) Febuxostat Tabletshehe Febuxostat (Polymorphs) Febuxostat (This product is unavailable in the U.S.) 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid |
CAS | 144060-53-7 |
EINECS | 682-158-6 |
化学式 | C16H16N2O3S |
分子量 | 316.37 |
InChI | InChI=1/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) |
密度 | 1.31±0.1 g/cm3(Predicted) |
熔点 | 238-239°(dec.) |
沸点 | 536.6±60.0 °C(Predicted) |
闪点 | 278.3°C |
蒸汽压 | 2.41E-12mmHg at 25°C |
溶解度 | DMSO (微溶) 、甲醇 (微溶) |
折射率 | 1.605 |
酸度系数 | 2.48±0.10(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | White to Off-White |
Merck | 14,3948 |
物化性质 | 规格;白色结晶粉末 熔点:201-202℃ |
MDL号 | MFCD00871598 |
RTECS | XJ3675310 |
参考资料 展开查看 | 1. Xu, Lieqiang, et al. "Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate-and Hypoxanthine-Induced Hyperuricemic Mice." Frontiers in Pharmacology 12 (2021): 804. 2. [IF=6.529] Haiyang Yang et al."Accurate quantitative determination of affinity and binding kinetics for tight binding inhibition of xanthine oxidase."Biomed Pharmacother. 2021 Jul;139:111664 3. [IF=5.81] Xu Lieqiang et al."Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice."Front Pharmacol. 2021 Apr;0:804 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!